Profil
Jacob Licht currently works at Exo-Top, Inc., as Chief Executive Officer from 2025 and NurExone Biologic, Inc., as Vice President-Corporate Development from 2025.
Mr. Licht also formerly worked at Emergent BioSolutions, Inc., as Vice President-Corporate Development from 2007 to 2017, Lantheus Medical Imaging, Inc., as Vice President-Business Development from 2021 to 2023, and Bavarian Nordic A, as Vice President-Corporate Development from 2019 to 2021.
Postes actifs de Jacob Licht
| Sociétés | Poste | Début |
|---|---|---|
| NUREXONE BIOLOGIC INC. | Corporate Officer/Principal | 22/04/2025 |
Anciens postes connus de Jacob Licht
| Sociétés | Poste | Fin |
|---|---|---|
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Develops and manufactures radio diagnostics | Corporate Officer/Principal | 01/04/2023 |
| BAVARIAN NORDIC A/S | Corporate Officer/Principal | 01/03/2021 |
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01/04/2017 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Develops and manufactures radio diagnostics | Health Technology |
Bavarian Nordic A/S
Bavarian Nordic A/S BiotechnologyHealth Technology Engages in research, development and manufacturing travel vaccines | Health Technology |
Emergent BioSolutions, Inc.
Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
NurExone Biologic, Inc.
NurExone Biologic, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops an off the shelf, non-invasive and revolutionary treatment for the reduction in the harmful results of spinal cord injury | Health Technology |
















